Reduced intensity reinduction followed by blinatumomab achieves excellent MRD clearance with reduced toxicity and facilitates timely transplant in children and young people with relapsed B-precursor acute lymphoblastic leukemia
Authors
Hodder, A.Mishra, A. K.
Clesham, K.
Baird, S.
Bhuller, K.
Bisho, I.
Bonney, D.
Castleton, Anna
Cummins, M.
Dickens, E.
George, L.
Ghorashian, S.
Gibson, B.
Hasley, C.
Heaney, N.
Hough, R. E.
Ingham, D.
Jigoulina, G.
Lindsay, K.
Lancaster, D.
Madni, M.
Malone, A.
Mitchell, B.
Moorman, A. V.
Moppett, J.
McLelland, V.
Motwani, J.
Nicholson, E.
Osborne, C.
Patrick, K.
Samrin, L.
Tewari, S.
Thakur, I. R.
Samarasinghe, S.
Vora, A.
O'Connor, D.
Affiliation
Department of Haematology, Great Ormond Street Hospital for Children, London,Issue Date
2022
Metadata
Show full item recordCitation
Hodder A, Mishra AK, Clesham K, Baird S, Bhuller K, Bisho I, et al. Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia. Blood. 2022 Nov;140:3268-70. PubMed PMID: WOS:000893223203136.Journal
BloodDOI
10.1182/blood-2022-162565Additional Links
https://dx.doi.org/10.1182/blood-2022-162565Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2022-162565